Navigation Links
Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/7/2009

al achieved the primary endpoint of median Time to Last Unformed Stool (TLUS). Median TLUS for patients treated with prulifloxacin was 32.8 hours which was statistically significant compared to the TLUS for placebo with a p-value of less than 0.0001. Prulifloxacin was generally well tolerated and had a similar safety profile compared to placebo. This is the second of two pivotal Phase 3 clinical studies which will be used to support an NDA submission with the U.S. Food and Drug Administration.
  • Raised $32.9 million in gross proceeds through the sale of 3.3 million shares and warrants to purchase 91,533 shares in a registered direct offering in March 2009.
  • Appointed Francois-Xavier Frapaise, M.D., as Senior Vice President and Chief Scientific Officer and Peter E. Grebow, Ph.D., Executive Vice President of Worldwide Technical Operations at Cephalon, Inc. (Nasdaq: CEPH), to the company's Board of Directors.
  • Published in vitro data highlighting the antibacterial activity of prulifloxacin in the peer-reviewed journal Antimicrobial Agents and Chemotherapy.

    • About Optimer Pharmaceuticals

    Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. Fidaxomicin, formerly known as OPT-80, is the only antibiotic therapy currently in Phase 3 worldwide clinical development for Clostridium difficile infection. Prulifloxacin is an antibiotic which has completed two Phase 3 clinical trials for the treatment of travelers' diarrhea, a form of infectious diarrhea. Additional information can be found at

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5

    Related biology technology :

    1. Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
    2. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
    3. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
    4. Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
    5. First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals GGTI-2418
    6. BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals
    7. Idenix Pharmaceuticals Reports First Quarter Financial Results
    8. Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting
    9. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
    10. OncoGenex Pharmaceuticals to Release First Quarter Financial Results
    11. Vanda Pharmaceuticals Reports First Quarter 2009 Results

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/6/2009)...ewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:...today announced updated results from a Phase II st...rcomas metastatic to the lung in a poster presenta... Society Meeting held in Miami Beach, Florida, fro...titled "A Phase II Study of Intravenous REOLYSIN (...
    (Date:11/5/2009)...ov. 5 GenVec, Inc. (Nasd...for the third quarter ended September 30, 2009. Ge...r share) for the three months ended September 30, ... per share) in the comparable quarter of 2008. For...s net loss was $14.1 million ($0.15 per share), co...
    (Date:11/5/2009)...f., Nov. 5 ThermoGenesis...ovative products for processing and storing adult ...uarter of fiscal 2010. ,, For the quarter ended... of $5.2 million, a 15 percent increase over reven...o. The Company said the key contributors to the gr...
    (Date:11/5/2009)...ov. 5 Cepheid (Nasdaq: ... speaking at the following investor conferences, a... , Credit Suisse Healthcare Confer...vember, 2009 at 10 a.m. Mountain Time, ...gland, Tuesday, 1 December, 2009 a...
    Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
    ...announced that,Johnson & Johnson Vice Chairman, Ch...s statewide Expo and Conference November 18-19 in ...igan,s life science industry,and its annual Expo i...g,more than 450 attendees and 60 exhibitors last y...fessionals in the industry,and we are absolutely t...
    ...Kee (Recruiter and Owner of PHC Consulting) hasn&#...s focused on top sales and sales support talent in...earch, physician call points, medical devices, pha...r for revenues and Peggy attributes that growth to... Celina, TX (PRWEB) June 24, 2008 -- http://www.p...
    ... Inc., (OTCBB:BTIM) and BioTime’s wholly-own... a manufacturing and distribution agreement with I...rough its wholly-owned subsidiary Lifeline Cell Te...ute hundreds of new standardized human and animal ... reagents. The mutual goal is to provide the ̶...
    Other Biology Technology:Christine Poon Will Keynote MichBio Expo 2Christine Poon Will Keynote MichBio Expo 3Website and Blog Increase Placement for Medical Sales Recruiter - Providing Sales Winners Calling on the Hospital, Lab and Physician Call Point 2 BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use 2 BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use 3 BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use 4 BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use 5
    (Date:11/4/2009)...v. 4 GenVault Corporation (Carlsba...h.D., has joined its Board of Directors. Dr. Brod... Institute, is an acclaimed physician-scientist an...stitute, Dr. Brody served as president of The John...nal Academy of Engineering and the Institute of Me...
    (Date:11/3/2009)..., 2009 -- The world,s greatest wines are the resu...an input, and something called the "terroir" -- a ... climate. , Experts will discuss terroir with ...esday, Nov. 4 in Pittsburgh. "Terroir: Winegrapes...ts at the 2009 Annual Meetings of the American Soc...
    (Date:11/3/2009)...he ultimate loner of the ocean, cruising thousands...chers has discovered that the sharks have maintain...r tens of thousands of years the white sharks in t...elves into a population genetically distinct from ...re a large, highly mobile species," said Salvador ...
    Breaking Biology News(10 mins):Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Great wines come from great soils 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 1PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 2PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 3The Omics Generation on Facebook 55415 1The Omics Generation on Facebook 55415 2Roper Industries Announces Proposed Public Offering of Senior Unsecured Notes due 2019 55412 1Roper Industries Announces Proposed Public Offering of Senior Unsecured Notes due 2019 55412 2Roper Industries Announces Proposed Public Offering of Senior Unsecured Notes due 2019 55412 3
    ...New Haven, Conn. If climate disasters are to be a...educed below the levels that already exist today, ...ic Science Journal by a group of 10 scientists f...ce. , The authors, who include two Yale scienti...hat on which civilization developed, an optimum CO...
    ...SALT LAKE CITY A group of paleontologists visited..."dinosaur dance floor" and concluded there were no... unusual potholes eroded in the sandstone. , So ...eology department says she will team up with the s...evolving process where we seek the truth," says Ma...
    ...lementary school students will eat more whole grai...roduced into their school lunches, a new Universit...are strongly recommended as part of a healthy diet.... For this study, researchers from the university,...ed how much bread students threw away, and whether...
    Other Biology News:Revised theory suggests carbon dioxide levels already in danger zone 2Paleontologists doubt 'dinosaur dance floor' 2
    7500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
    Safety Glasses Dispensers from Terra Universal, Inc.
    Apparel Dispenser from Terra Universal, Inc.
    ...A expression profiling and built on the flexible a... platform. These microarrays are available as part...g Service. Probe Content The Mammals microRNA M... unique mature sequences). The comprehensive probe...
    Biology Products: